CONFORM Pivotal Trial Site Recruitment Meeting

Published: 16 June 2021

  • Views:

    Views Icon 1216

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

The CONFORM Pivotal Trial is a prospective, multi-center randomized controlled trial, designed to evaluate the safety and effectiveness of the Conformal Left Atrial Appendage Seal (CLAAS®). Subjects will be randomized in a 1:1 fashion between the CLAAS device (treatment) or a Boston Scientific LAA closure device (Control).

 

If interested in participating in the Conform Pivotal Study, please contact Karis Oasan, Clinical Trial Manager koasan@conformalmedical.com.

 

For more information on Conformal Medical, Inc click HERE to visit our website.

This session is a clinical trial recruitment event.

Target Audience

  • Interventional Cardiologists
  • Electrophysiologists
  • All sites specialising in LAA procedures or doing research in this space

More from this programme

Part 1

Welcome and Introductions

Presented by Andy Levine
1 session
Welcome and Introductions Watch now

Part 2

CLAAS Overview

Presented by Dr Aaron Kaplan
1 session
CLAAS Overview Watch now

Part 3

Initial Clinical Experience

Presented by Dr Aaron Kaplan
1 session
Initial Clinical Experience Watch now

Part 4

Case Study and Panel Discussion 1

Presented by Dr William Gray with discussion moderated by Dr Aaron Kaplan and Dr Shephal Doshi
1 session
Case Study and Panel Discussion 1 Watch now

Part 5

Case Study and Panel Discussion 2

Presented by Dr Vivek Reddy with discussion moderated by Dr Aaron Kaplan and Dr Shephal Doshi
1 session
Case Study and Panel Discussion 2 Watch now

Part 6

CONFORM Pivotal Trial Summary

Presented by Chris Cain
1 session
CONFORM Pivotal Trial Summary Watch now

Part 7

Closing Remarks

Presented by Dr Aaron Kaplan
1 session
Closing Remarks Watch now

Faculty Biographies

Aaron Kaplan

Aaron Kaplan

Chairman and Chief Medical Officer

Aaron Kaplan is an active medical device entrepreneur who has been on the founding team of a number of venture-backed medical device companies including Conformal Medical, Tryton Medical, LocalMed and Perclose (acquired by Abbott).  He has consulted to many medical device companies and was an Entrepreneur-In-Residence at Three Arch Partners.

 

Aaron is a practicing interventional cardiologist at Dartmouth-Hitchcock Medical Center and a Professor of Medicine at the Geisel School of Medicine at Dartmouth. In addition, he directs the Synergy Clinician-Entrepreneur Fellowship and chairs the Dartmouth Device Development Symposium. Prior to joining the Dartmouth Faculty, Dr. Kaplan was Director of Interventional Cardiology at…

View full profile